Bleakley Financial Group LLC Grows Stake in GE HealthCare Technologies Inc. (NASDAQ:GEHC)

Bleakley Financial Group LLC grew its holdings in shares of GE HealthCare Technologies Inc. (NASDAQ:GEHC) by 3.8% during the 4th quarter, according to its most recent Form 13F filing with the SEC. The firm owned 17,119 shares of the company’s stock after buying an additional 624 shares during the period. Bleakley Financial Group LLC’s holdings in GE HealthCare Technologies were worth $1,338,000 as of its most recent SEC filing.

A number of other hedge funds and other institutional investors also recently made changes to their positions in GEHC. LGT Financial Advisors LLC raised its holdings in GE HealthCare Technologies by 1,673.3% in the 3rd quarter. LGT Financial Advisors LLC now owns 266 shares of the company’s stock worth $25,000 after purchasing an additional 251 shares in the last quarter. Capital Performance Advisors LLP purchased a new position in shares of GE HealthCare Technologies during the third quarter valued at about $26,000. Ashton Thomas Securities LLC bought a new position in GE HealthCare Technologies in the third quarter worth about $26,000. Darwin Wealth Management LLC purchased a new stake in GE HealthCare Technologies in the third quarter worth about $31,000. Finally, Continuum Advisory LLC boosted its position in GE HealthCare Technologies by 101.8% during the 3rd quarter. Continuum Advisory LLC now owns 333 shares of the company’s stock valued at $31,000 after acquiring an additional 168 shares in the last quarter. Institutional investors own 82.06% of the company’s stock.

Wall Street Analyst Weigh In

Several research analysts have recently issued reports on the company. Jefferies Financial Group raised GE HealthCare Technologies from a “hold” rating to a “buy” rating and increased their target price for the stock from $95.00 to $103.00 in a research report on Wednesday, January 8th. Wells Fargo & Company raised their price objective on GE HealthCare Technologies from $95.00 to $96.00 and gave the company an “overweight” rating in a research report on Thursday, October 31st. One research analyst has rated the stock with a sell rating, four have issued a hold rating, nine have given a buy rating and one has issued a strong buy rating to the stock. Based on data from MarketBeat, the stock has an average rating of “Moderate Buy” and a consensus target price of $96.00.

GE HealthCare Technologies Stock Performance

Shares of GEHC stock opened at $87.64 on Friday. The company has a market capitalization of $40.04 billion, a price-to-earnings ratio of 24.08, a price-to-earnings-growth ratio of 2.92 and a beta of 1.14. The company has a debt-to-equity ratio of 1.12, a quick ratio of 0.98 and a current ratio of 1.23. GE HealthCare Technologies Inc. has a one year low of $74.51 and a one year high of $94.55. The company’s 50-day moving average is $83.34 and its 200 day moving average is $85.21.

GE HealthCare Technologies Increases Dividend

The company also recently declared a quarterly dividend, which will be paid on Friday, February 14th. Stockholders of record on Tuesday, January 14th will be issued a dividend of $0.035 per share. This is a boost from GE HealthCare Technologies’s previous quarterly dividend of $0.03. The ex-dividend date is Tuesday, January 14th. This represents a $0.14 dividend on an annualized basis and a dividend yield of 0.16%. GE HealthCare Technologies’s dividend payout ratio is presently 3.85%.

About GE HealthCare Technologies

GE HealthCare Technologies Inc engages in the development, manufacture, and marketing of products, services, and complementary digital solutions used in the diagnosis, treatment, and monitoring of patients in the United States, Canada, and internationally. The company operates through four segments: Imaging, Ultrasound, Patient Care Solutions, and Pharmaceutical Diagnostics.